AI-Driven Drug Discovery in Neuropharmacology

This track is dedicated to the application of artificial intelligence and machine learning in drug discovery for neuropharmacology. Researchers are invited to submit abstracts on AI-driven methods for identifying new drug candidates, predicting drug efficacy and safety, and optimizing drug design. The track will cover innovative computational approaches that accelerate the drug discovery process, from target identification to preclinical development. Attendees can expect to learn about the latest tools and technologies that are transforming neuropharmacology, making drug development more efficient and precise.

    Related Conference of AI-Driven Drug Discovery in Neuropharmacology

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    AI-Driven Drug Discovery in Neuropharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in